John K Bakewell is of TREACE MEDICAL CONCEPTS, INC.. Currently has a direct ownership of 150,139 shares of TMCI, which is worth approximately $1.24 Million. The most recent transaction as insider was on May 21, 2024, when has been sold 15,091 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 150K
0% 3M change
2874.23% 12M change
Total Value Held $1.24 Million

JOHN K BAKEWELL Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 21 2024
BUY
Grant, award, or other acquisition
-
15,091 Added 9.13%
150,139 Common Stock
May 10 2024
BUY
Open market or private purchase
$594,100 $4.57 p/Share
130,000 Added 49.05%
135,048 Common Stock
May 23 2023
BUY
Grant, award, or other acquisition
-
2,753 Added 35.29%
5,048 Common Stock
May 17 2022
BUY
Grant, award, or other acquisition
-
2,295 Added 50.0%
2,295 Common Stock

Also insider at

STIM
Neuronetics, Inc. Healthcare
XTNT
Xtant Medical Holdings, Inc. Healthcare
JKB

John K Bakewell

Belgrade, MT

Track Institutional and Insider Activities on TMCI

Follow TREACE MEDICAL CONCEPTS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TMCI shares.

Notify only if

Insider Trading

Get notified when an Treace Medical Concepts, Inc. insider buys or sells TMCI shares.

Notify only if

News

Receive news related to TREACE MEDICAL CONCEPTS, INC.

Track Activities on TMCI